These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2610698)
21. Relationship between levels of Clostridium difficile toxin A and toxin B and cecal lesions in gnotobiotic mice. Vernet A; Corthier G; Dubos-Ramaré F; Parodi AL Infect Immun; 1989 Jul; 57(7):2123-7. PubMed ID: 2499546 [TBL] [Abstract][Full Text] [Related]
22. Modification of apolipoprotein C-II with 1,2-cyclohexanedione and 2,3-butanedione. Role of arginine in the activation of lipoprotein lipase. Holdsworth G; Noel JG; Stedje K; Shinomiya M; Jackson RL Biochim Biophys Acta; 1984 Jul; 794(3):472-8. PubMed ID: 6743677 [TBL] [Abstract][Full Text] [Related]
23. The low molecular mass GTP-binding protein Rho is affected by toxin A from Clostridium difficile. Just I; Selzer J; von Eichel-Streiber C; Aktories K J Clin Invest; 1995 Mar; 95(3):1026-31. PubMed ID: 7883950 [TBL] [Abstract][Full Text] [Related]
24. Modification of arginine residues in human growth hormone by 1,2-cyclohexanedione: effects on the binding capacity to lactogenic and somatogenic receptors. Atlasovich FM; Caridad JJ; Nowicki C; Santomé JA; Wolfenstein-Todel C Arch Biochem Biophys; 1990 Aug; 281(1):1-5. PubMed ID: 2166475 [TBL] [Abstract][Full Text] [Related]
25. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins. Chen S; Sun C; Wang H; Wang J Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511 [TBL] [Abstract][Full Text] [Related]
27. Production of monoclonal antibody to Clostridium difficile toxin A which neutralizes enterotoxicity but not haemagglutination activity. Kamiya S; Yamakawa K; Meng XQ; Ogura H; Nakamura S FEMS Microbiol Lett; 1991 Jul; 65(3):311-5. PubMed ID: 1916231 [TBL] [Abstract][Full Text] [Related]
28. Purification and some properties of cytotoxin produced by Clostridium difficile. Katoh T; Honda T; Miwatani T Microbiol Immunol; 1988; 32(6):551-64. PubMed ID: 3173147 [TBL] [Abstract][Full Text] [Related]
29. Antitoxin activity of human polymorphonuclear leucocytes. Larson HE; Smith GP; Shah L Br J Exp Pathol; 1985 Apr; 66(2):243-9. PubMed ID: 2859049 [TBL] [Abstract][Full Text] [Related]
30. Identification of the C-1-phosphate-binding arginine residue of rabbit-muscle aldolase. Isolation of 1,2-cyclohexanedione-labeled peptide by chemisorption chromatography. Patthy L; Váradi A; Thész J; Kovács K Eur J Biochem; 1979 Sep; 99(2):309-13. PubMed ID: 499203 [TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity of Clostridium difficile toxins A and B requires an active and functional SREBP-2 pathway. Papatheodorou P; Song S; López-Ureña D; Witte A; Marques F; Ost GS; Schorch B; Chaves-Olarte E; Aktories K FASEB J; 2019 Apr; 33(4):4883-4892. PubMed ID: 30592645 [TBL] [Abstract][Full Text] [Related]
32. Simplified purification method for Clostridium difficile toxin A. Fu SW; Xue J; Zhang YL; Zhou DY World J Gastroenterol; 2004 Sep; 10(18):2756-8. PubMed ID: 15309736 [TBL] [Abstract][Full Text] [Related]
33. A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model. Anosova NG; Cole LE; Li L; Zhang J; Brown AM; Mundle S; Zhang J; Ray S; Ma F; Garrone P; Bertraminelli N; Kleanthous H; Anderson SF Clin Vaccine Immunol; 2015 Jul; 22(7):711-25. PubMed ID: 25924765 [TBL] [Abstract][Full Text] [Related]
34. Immunochemical and structural similarities in toxin A and toxin B of Clostridium difficile shown by binding to monoclonal antibodies. Rothman SW; Gentry MK; Brown JE; Foret DA; Stone MJ; Strickler MP Toxicon; 1988; 26(6):583-97. PubMed ID: 2459808 [TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity of Clostridium difficile toxin A for human colonic and pancreatic carcinoma cell lines. Kushnaryov VM; Redlich PN; Sedmak JJ; Lyerly DM; Wilkins TD; Grossberg SE Cancer Res; 1992 Sep; 52(18):5096-9. PubMed ID: 1516066 [TBL] [Abstract][Full Text] [Related]
36. The American cockroach peptide periplanetasin-4 inhibits Clostridium difficile toxin A-induced cell toxicities and inflammatory responses in the mouse gut. Yoon IN; Lu LF; Hong J; Zhang P; Kim DH; Kang JK; Hwang JS; Kim H J Pept Sci; 2017 Nov; 23(11):833-839. PubMed ID: 28949065 [TBL] [Abstract][Full Text] [Related]
37. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. Chaves-Olarte E; Weidmann M; Eichel-Streiber C; Thelestam M J Clin Invest; 1997 Oct; 100(7):1734-41. PubMed ID: 9312171 [TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes. Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484 [TBL] [Abstract][Full Text] [Related]
39. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A. Torres JF J Med Microbiol; 1991 Jul; 35(1):40-4. PubMed ID: 1906544 [TBL] [Abstract][Full Text] [Related]
40. Association between production of toxins A and B and types of Clostridium difficile. Wren B; Heard SR; Tabaqchali S J Clin Pathol; 1987 Dec; 40(12):1397-401. PubMed ID: 3123524 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]